TherapeuticsMD (TXMD) Other Working Capital Changes (2010 - 2026)
TherapeuticsMD (TXMD) posted Other Working Capital Changes of $1000.0 for Q1 2026, up 100.06% on a QoQ basis from -$1.7 million in Q4 2025, and up 100.49% year-over-year from $498.77 in Q1 2025.
TherapeuticsMD (TXMD) Other Working Capital Changes (2010 - 2026) Analysis & Trends
TherapeuticsMD's Other Working Capital Changes history runs 8 years deep, the most recent figure standing at $1000.0 for Q1 2026.
- Quarterly Other Working Capital Changes rose 100.49% year-over-year to $1000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$874000.0 (down 840.68% YoY) and the FY2025 annual result came in at -$1.1 million, down 1098.15% from the prior year.
- Other Working Capital Changes was $1000.0 for Q1 2026 at TherapeuticsMD, up from -$1.7 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $10.1 million in Q2 2022 and bottomed at -$9.4 million in Q3 2022.
- A 5-year average of -$164235.3 and a median of -$433000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 12950.0% in 2023, while the deepest fall reached 15700.0% in 2023.
- TherapeuticsMD's Other Working Capital Changes stood at $264000.0 in 2022, then tumbled by 40.15% to $158000.0 in 2023, then tumbled by 393.67% to -$464000.0 in 2024, then sank by 258.84% to -$1.7 million in 2025, then jumped by 100.06% to $1000.0 in 2026.
- Business Quant data shows TXMD's Other Working Capital Changes at $1000.0 in Q1 2026, -$1.7 million in Q4 2025, and $217000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -881,000.00 |
| Mar 31, 2026 | -881,000.00 |
| Mar 31, 2026 | -881,000.00 |
| Dec 31, 2025 | -619,000.00 |
| Dec 31, 2025 | -619,000.00 |
| Dec 31, 2025 | -619,000.00 |
| Sep 30, 2025 | -529,000.00 |
| Sep 30, 2025 | -529,000.00 |
| Sep 30, 2025 | -529,000.00 |
| Jun 30, 2025 | -439,000.00 |
| Jun 30, 2025 | -439,000.00 |
| Jun 30, 2025 | -439,000.00 |
| Mar 31, 2025 | -433,000.00 |
| Mar 31, 2025 | -433,000.00 |
| Mar 31, 2025 | -433,000.00 |
| Dec 31, 2024 | -380,000.00 |
| Dec 31, 2024 | -380,000.00 |
| Dec 31, 2024 | -380,000.00 |
| Sep 30, 2024 | 1.24 Mn |
| Sep 30, 2024 | 1.24 Mn |